The purpose of this study is to compare the effects, good or bad, of targeted therapies or
immunotherapy on patients who have solid tumors with specific genetic alterations or with a high number of mutations. Patients will be assigned to cohorts based on having a specific type of genetic alteration or having a high number of mutations in their tumor.
using somatic alterations and potential predictive biomarkers identified via NGS assays
in patients with solid tumors.